MLAK news

Latest 1 stories · newest Jun 25, 2026

MLAK

MoonLake enters underwriting agreement for 10M share offering

MoonLake Immunotherapeutics entered an underwriting agreement with Leerink Partners to sell up to 10 million ordinary shares and warrants. This public offering, including an option to purchase additional securities, aims to provide capital for business operations and growth.

Offering Jun 25, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same MLAK feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/MLAK/newsSTART FREE